Intriguingly, with the refinement of large-scale gene expression profiling and the advancement of synthetic tools with various multi-omics algorithms, it is feasible to perform pan-cancer expression analysis of IFI30 and assess its correlation with a range of features of the tumor immune microenvironment to maximize the immune potential of this target (19, 20). This evidence concerns the gene IFI30 and neoplasm.